Targeted Therapy of AML1/ETO-Positive AML Cells in Experimental Model

被引：0
|
作者：
Zapotocky, Michal [1 ]
Starkova, Julia [1 ]
Mejstrikova, Ester [1 ]
Smetana, Karel [2 ]
Trka, Jan [1 ]
机构：
[1] Charles Univ Prague, Sch Med 2, CLIP, Prague, Czech Republic
[2] Charles Univ Prague, Sch Med 1, Inst Hematol & Blood Transfus, Prague, Czech Republic
来源：
BLOOD | 2008年 / 112卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1153 / 1153
页数：1
相关论文
共 50 条
  • [41] A Case of AML1/ETO Positive Child with Acute Myeloid Leukemia with Poor Prognosis
    Zhang, Xiaofang
    Wu, Yiping
    Wang, Lihua
    Li, Haixin
    Li, Ruimin
    CLINICAL LABORATORY, 2023, 69 (02) : 410 - 413
  • [42] Heterodimerization of AML1/ETO with CBFβ is required for leukemogenesis but not for myeloproliferation
    V N Thiel
    B D Giaimo
    P Schwarz
    K Soller
    V Vas
    M Bartkuhn
    T J Blätte
    K Döhner
    L Bullinger
    T Borggrefe
    H Geiger
    F Oswald
    Leukemia, 2017, 31 : 2491 - 2502
  • [43] Heterodimerization of AML1/ETO with CBFβ is required for leukemogenesis but not for myeloproliferation
    Thiel, V. N.
    Giaimo, B. D.
    Schwarz, P.
    Soller, K.
    Vas, V.
    Bartkuhn, M.
    Blaette, T. J.
    Doehner, K.
    Bullinger, L.
    Borggrefe, T.
    Geiger, H.
    Oswald, F.
    LEUKEMIA, 2017, 31 (11) : 2491 - 2502
  • [44] Dominant negative effects of the AML1/ETO fusion oncoprotein
    Fenske, TS
    Pengue, G
    Graubert, TA
    CELL CYCLE, 2005, 4 (01) : 33 - 36
  • [45] Comparison of karyotype analysis and RT PCR for AML1/ETO in 204 unselected patients with AML
    Mitterbauer, M
    Kusec, R
    Schwarzinger, I
    Haas, OA
    Lechner, K
    Jaeger, U
    ANNALS OF HEMATOLOGY, 1998, 76 (3-4) : 139 - 143
  • [46] Time- and residue-specific differences in histone acetylation induced by VPA and SAHA in AML1/ETO-positive leukemia cells (vol 8, pg 210, 2013)
    Barbetti, Valentina
    Gozzini, Antonella
    Cheloni, Giulia
    Marzi, Ilaria
    Fabiani, Emiliano
    Santini, Valeria
    Dello Sbarba, Persio
    Rovida, Elisabetta
    EPIGENETICS, 2013, 8 (12) : 1384 - 1384
  • [47] Proteomics of AML1/ETO target proteins: AML1-ETO targets a C/EBP-NM23 pathway
    Singh S.M.
    Trivedi A.K.
    Lochab S.
    Christopeit M.
    Hiddemann W.
    Behre G.
    Clinical Proteomics, 2010, 6 (3) : 83 - 91
  • [48] AML1/ETO promotes the expansion of early human hematopoietic stem cells.
    Mulloy, JC
    Cammenga, J
    MacKenzie, KL
    Moore, MAS
    Nimer, SD
    BLOOD, 2000, 96 (11) : 572A - 572A
  • [49] Novel role of HDAC inhibitors in AML1/ETO AML cells: activation of apoptosis and phagocytosis through induction of annexin A1
    Y Tabe
    L Jin
    R Contractor
    D Gold
    P Ruvolo
    S Radke
    Y Xu
    Y Tsutusmi-Ishii
    K Miyake
    N Miyake
    S Kondo
    A Ohsaka
    I Nagaoka
    M Andreeff
    M Konopleva
    Cell Death & Differentiation, 2007, 14 : 1443 - 1456
  • [50] PIG7, transactivated by AML1, promotes apoptosis and differentiation of leukemia cells with AML1-ETO fusion gene
    Liu, J.
    Xing, H.
    Chen, Y.
    Wang, L.
    Wang, D.
    Rao, Q.
    Tang, K.
    Tian, Z.
    He, K.
    Wang, M.
    Wang, J.
    LEUKEMIA, 2012, 26 (01) : 117 - 126
12345